{
 "PrintNo":"S7413","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-05-23T16:19:41.86536Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-05-23","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":372,"Name":"Neil D. Breslin","Short":"BRESLIN"}],
 "Title":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "Summary":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain \"brown bagging\" and \"white bagging\" policies regarding pharmacy provided medications.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3217-b & 4325, Ins L; amd §4406-c, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to establishing patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "SameAsPrintNo":"A2163-2023","PreviousVersions":["S7252-2021"]
}